From: ATM rs189037 (G > A) polymorphism increased the risk of cancer: an updated meta-analysis
Author | Year | Region | Ethnicity | Controls source | Type of cancer | Genotyping method | Case/control | Male(case/control) | NOS scores |
---|---|---|---|---|---|---|---|---|---|
Kim | 2006 | Korea | East Asian | hospital-based | lung cancer | SNaPShot assay | 616/616 | 483/483 | 4 |
Wang | 2010 | Taiwan | East Asian | hospital-based | breast cancer | PCR-RFLP | 1232/1232 | 0/0 | 5 |
Bau | 2010 | Taiwan | East Asian | hospital-based | oral cancer | PCR-RFLP | 620/620 | 586/582 | 5 |
Lo | 2010 | Taiwan | East Asian | hospital-based | lung cancer | MassARRAY | 730/730 | 384/384 | 5 |
Wang | 2011 | Taiwan | East Asian | hospital-based | leukemia | PCR-RFLP | 266/266 | 148/148 | 5 |
Xu | 2012 | Brazil | Latino | hospital-based | differentiated thyroid cancer | TaqMan | 592/885 | 146/379 | 6 |
Hsia | 2013 | Taiwan | East Asian | hospital-based | lung cancer | PCR-RFLP | 358/716 | 254/488 | 5 |
Zhao | 2013 | China | East Asian | hospital-based | glioma | TaqMan | 384/384 | 222/217 | 6 |
Damiola | 2013 | Belarus | Caucasian | population-based | papillary thyroid carcinoma | Illumina GoldenGate Genotyping Assay | 83/324 | 35/127 | 7 |
Gu | 2014 | China | East Asian | hospital-based | papillary thyroid carcinoma | MALDI-TOF-MS | 358/360 | 109/115 | 4 |
Liu | 2014 | China | East Asian | population-based | lung cancer | TaqMan | 852/852 | 485/490 | 5 |
Shen | 2014 | China | East Asian | hospital-based | lung cancer | TaqMan | 487/516 | 0/0 | 5 |
Song | 2014 | Korea | East Asian | hospital-based | papillary thyroid carcinoma | TaqMan | 437/184 | 93/51 | 6 |
Yue | 2018 | China | East Asian | hospital-based | breast cancer | ligase detection reaction method | 524/518 | 0/0 | 4 |
Wang | 2018 | China | East Asian | hospital-based | colorectal cancer | TaqMan | 1121/1056 | 631/561 | 5 |